EUVIMEDEUVIMED entdecken
Open Access

Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey

Giulia Maria Stella, Valerio Maria Carrozzo, Sara Lettieri, Giulia Alaimo, Enrica Capelletto, Paolo Cameli, Laura Carrozzi, Fabrizio Luppi, Fabio Perrotta

Multidisciplinary Respiratory Medicine · 15.05.2026 · 21 (Vol. 21 (2026)) · 1072

DOI: 10.5826/mrm.2026.1072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multidisciplinary Respiratory Medicine, erschienen am 15.05.2026. Verfasst von Giulia Maria Stella und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Pavia. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coexistence of interstitial lung disease (ILD), particularly idiopathic pulmonary fibrosis (IPF), and lung cancer poses major diagnostic and therapeutic challenges, yet clinical management remains heterogeneous. The project aims to describe current Italian practices for integrated management of ILD with concomitant lung cancer.

Methods

ICARO (Interstiziopatia e Cancro del polmone: AppRoccio al management clinico integratO) is a national cross-sectional clinician survey conducted in Italy on behalf of the Italian Respiratory Society from November 2024 to March 2025. A 12-item multiple-choice questionnaire assessed diagnostic strategies, treatment preferences, and perceived toxicity risks. Invitations were sent to X physicians, among which 38 ansewered (35 specialists and senior 3 registrars (age range: 28–68 years).

Results

An ILD multidisciplinary team was available in 26/38 (71.1%) centres. Diagnostic procedures for lung cancer in ILD patients were reported as performed “always/often” by 14/38 (36.8%), with the main concern being ILD progression after procedures (31/38 - 81.6%). Most respondents continued antifibrotic therapy during systemic cancer treatment (28/38- 73.7%). Combined chemotherapy plus immune checkpoint inhibitors was perceived as the highest-risk regimen by 19/38 physicians (50%), and 20/38 (52.6%) were hesitant to offer neoadjuvant immunotherapy in stage II–IIIa NSCLC. Severe toxicity from radiotherapy was reported as frequent by 8/38 (21.1%).

Conclusions

Italian clinicians report substantial variability in diagnostic and therapeutic strategies for lung cancer in ILDs, driven mainly by concern for ILD progression and treatment-related pulmonary toxicity. Although limited, this study unveils an urgent need for further prospective studies to better define the safety and efficacy of combined therapeutic approaches and to establish evidence-based guidelines to support clinical decision-making

Schlagwörter

Stichwörter der Autor:innen

Personalised medicinediagnosisidiopathic pulmonary fibrosis, IPF, treatment, therapy, future perspectiveslung cancer

Autor:innen und Institutionen

  • University of Pavia.
  • Università della Campania.
  • IRCCS Policlinico San Matteo.
  • San Luigi University Hospital, Orbassano.
  • Università di Siena.
  • Università di Pisa.

Zitieren

APA

Stella, G. M., Carrozzo, V. M., Lettieri, S., Alaimo, G., Capelletto, E., Cameli, P., Carrozzi, L., Luppi, F., & Perrotta, F. (2026). Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey. Multidisciplinary Respiratory Medicine, 21(Vol. 21 (2026)), 1072. https://doi.org/10.5826/mrm.2026.1072

Vancouver

Stella GM, Carrozzo VM, Lettieri S, Alaimo G, Capelletto E, Cameli P, et al. Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey. Multidisciplinary Respiratory Medicine. 2026;21(Vol. 21 (2026)):1072. doi:10.5826/mrm.2026.1072

BibTeX
@article{Stella2026,
  author = {Stella, Giulia Maria and Carrozzo, Valerio Maria and Lettieri, Sara and Alaimo, Giulia and Capelletto, Enrica and Cameli, Paolo and Carrozzi, Laura and Luppi, Fabrizio and Perrotta, Fabio},
  title = {Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey},
  journal = {Multidisciplinary Respiratory Medicine},
  year = {2026},
  volume = {21},
  number = {Vol. 21 (2026)},
  pages = {1072},
  doi = {10.5826/mrm.2026.1072}
}
Kostenlos starten →